Effect of honokiol on activity of GAD 65 and GAD 67 in the cortex and hippocampus of mice

Phytomedicine

Volumn 18, Issue 13, 2011, Pages 1126-1129

  Ku, Tien Hsiung ^a   Lee, Yih Jing ^b   Wang, Su Jane ^b   Fan, Chen Hua ^b   Tien, Lu Tai ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Cortex; Glutamic acid decarboxylase; Hippocampus; Honokiol; Magnolia officinalis

Indexed keywords

DIAZEPAM; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; HONOKIOL; ISOENZYME; PROTEIN;

AMINO ACID SYNTHESIS; ARTICLE; BRAIN CORTEX; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GABAERGIC TRANSMISSION; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BIPHENYL COMPOUNDS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CEREBRAL CORTEX; DIAZEPAM; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; LIGNANS; MAGNOLIA; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS;

MAGNOLIA; MAGNOLIA OFFICINALIS; MUS;

EID: 80053909786     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.03.007     Document Type: Article

References (27)

1. H. Asada, Y. Kawamura, K. Maruyama, H. Kume, R. Ding, F.Y. Ji, N. Kanbara, H. Kuzume, M.M. Sanbo, T. Yagi, and K. Obata Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures Biochem. Biophys. Res. Commun. 229 1996 891 895 (Pubitemid 27035813)
2. A. Breier, and S.M. Paul The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety J. Psychiatry Res. Suppl. 2 1990 91 104 (Pubitemid 20374701)
3. J.M. Cloos, and V. Ferreira Current use of benzodiazepines in anxiety disorders Curr. Opin. Psychiatry 22 2009 90 95
4. G.R. Dawson, and M.D. Tricklebank Use of the elevated plus-maze in the search for novel anxiolytic agents Trends Pharmacol. Sci. 16 1995 33 36
5. M.G. Erlander, N.J. Tillakaratne, S. Feldblum, N. Patel, and A.J. Tobin Two genes encode distinct glutamate decarboxylase Neuron 7 1991 91 100
6. L.W. Fan, L.T. Tien, S. Tanaka, T. Ma, N. Chudapongse, S. Sinchaisuk, R.W. Rockhold, and I.K. Ho Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol Neuroscience 121 2003 1063 1074 (Pubitemid 37324605)
7. M. Fujita, H. Itokawa, and Y. Sashida Studies on the components of Magnolia obovata Thunb. 3. Occurrence of magnolol and honokiol in M. obovata and other allied plants Yakugaku Zasshi 93 1973 429 434
8. D.W. Gallager, and R.J. Primus Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change Biochem. Soc. Symp. 59 1993 135 151
9. W.E. Haefely Benzodiazepines Int. Anesthesiol. Clin. 26 1988 262 272 Review (Pubitemid 19001457)
10. S.F. Kash, R.S. Johnson, L.H. Tecott, J.L. Noebels, R.D. Mayfield, D. Hanahan, and S. Baekkeskov Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase Proc. Natl. Acad. Sci. U. S. A. 94 1997 14060 14065 (Pubitemid 28009709)
11. S.F. Kash, L.H. Tecott, C. Hodge, and S. Baekkeskov Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase Proc. Natl. Acad. Sci. U. S. A. 96 1999 1698 1703 (Pubitemid 29098514)
12. S.K. Kulkarni, and D.S. Reddy Animal behavioral models for testing antianxiety agents Methods Find. Exp. Clin. Pharmacol. 18 1996 219 230 (Pubitemid 26000069)
13. H. Kuribara, W.B. Stavinoha, and Y. Maruyama Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice J Pharm Pharmacol. 50 1998 819 826 (Pubitemid 28379279)
14. H. Kuribara, W.B. Stavinoha, and Y. Maruyama Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice J. Pharm. Pharmacol. 51 1999 97 103 (Pubitemid 29097276)
15. M. Lader Effectiveness of benzodiazepines: do they work or not? Expert Rev. Neurother. 8 2008 1189 1191
16. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology 92 1987 180 185 (Pubitemid 17072893)
17. Y. Maruyama, H. Kuribara, M. Morita, M. Yuzurihara, and S.T. Weintraub Identification of magnolol and honokiol in the anxiolytic extracts of Saiboku-to, an oriental herbal medicine J. Nat. Prod. 61 1998 135 138 (Pubitemid 28086994)
18. K.T. Olkkola, and J. Ahonen Midazolam and other benzodiazepines Handb. Exp. Pharmacol. 182 2008 335 360
19. 65 mediates increased GABA synthesis during intense neuronal activity in vivo J. Neurochem. 97 2006 385 396
20. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167 (Pubitemid 16239568)
21. R.J. Rodgers, and N.J. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol. Biochem. Behav. 52 1995 297 303
22. D.J. Shader, and R.I. Greenblatt Clinical use of the benzodiazepines Ration. Drug Ther. 15 1981 1 6
23. G.K. Shaw Detoxification: the use of benzodiazepines Alcohol Alcohol. 30 1995 765 770 (Pubitemid 26017476)
24. W. Sieghart Pharmacology of benzodiazepine receptors: an update J. Psychiatry Neurosci. 19 1994 24 29 (Pubitemid 24066601)
25. T.A. Smith Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment Br. J. Biomed. Sci. 58 2001 111 121 (Pubitemid 32566041)
26. P. Tyrer Benzodiazepine dependence: a shadowy diagnosis Biochem. Soc. Symp. 59 1993 107 119
27. P.J. Whiting GABA-A receptors: a viable target for novel anxiolytics? Curr. Opin. Pharmacol. 6 2006 24 29 Review (Pubitemid 43103816)